Determine the necessary mass, volume, or concentration for preparing a solution.
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
SKU | Size | Availability | Price | Qty |
---|---|---|---|---|
B608042-1mg | 1mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $39.90 | |
B608042-5mg | 5mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $109.90 | |
B608042-10mg | 10mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $169.90 | |
B608042-25mg | 25mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $349.90 | |
B608042-50mg | 50mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $559.90 |
Synonyms | BI 1015550|BI-1015550|1423719-30-5|I5DGT51IB8|GTPL12518|EX-A7747|BI1015550|HY-153192|CS-0654251|[1-[[(5R)-2-[4-(5-chloropyrimidin-2-yl)piperidin-1-yl]-5-oxo-6,7-dihydrothieno[3,2-d]pyrimidin-4-yl]amino]cyclobutyl]methanol|CYCLOBUTANEMETHANOL, 1-(((5R)-2-( |
---|---|
Specifications & Purity | 98% |
Storage Temp | Store at -20°C |
Shipped In | Ice chest + Ice pads |
Grade | Moligand™ |
Action Type | INHIBITOR |
Mechanism of action | Inhibitor of phosphodiesterase 4A;Inhibitor of phosphodiesterase 4B;Inhibitor of phosphodiesterase 4D |
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
IUPAC Name | [1-[[(5R)-2-[4-(5-chloropyrimidin-2-yl)piperidin-1-yl]-5-oxo-6,7-dihydrothieno[3,2-d]pyrimidin-4-yl]amino]cyclobutyl]methanol |
---|---|
INCHI | InChI=1S/C20H25ClN6O2S/c21-14-10-22-17(23-11-14)13-2-7-27(8-3-13)19-24-15-4-9-30(29)16(15)18(25-19)26-20(12-28)5-1-6-20/h10-11,13,28H,1-9,12H2,(H,24,25,26)/t30-/m1/s1 |
InChi Key | UHYCLWAANUGUMN-SSEXGKCCSA-N |
Canonical SMILES | OCC1(CCC1)NC2=NC(=NC3=C2[S@](=O)CC3)N4CCC(CC4)C5=NC=C(Cl)C=N5 |
Isomeric SMILES | C1CC(C1)(CO)NC2=NC(=NC3=C2[S@](=O)CC3)N4CCC(CC4)C5=NC=C(C=N5)Cl |
PubChem CID | 166177189 |
Molecular Weight | 448.97 |
PubChem CID | 166177189 |
---|---|
CAS Registry No. | 1423719-30-5 |
Enter Lot Number to search for COA:
To view the certificate results,please click on a Lot number.For Lot numbers from past orders,please use our order status section
Lot Number | Certificate Type | Date | Item |
---|---|---|---|
B2418005 | Certificate of Analysis | Jan 05, 2024 | B608042 |
B2418006 | Certificate of Analysis | Jan 05, 2024 | B608042 |
B2418052 | Certificate of Analysis | Jan 05, 2024 | B608042 |
B2418053 | Certificate of Analysis | Jan 05, 2024 | B608042 |
B2418056 | Certificate of Analysis | Jan 05, 2024 | B608042 |
B2418058 | Certificate of Analysis | Jan 05, 2024 | B608042 |
B2418059 | Certificate of Analysis | Jan 05, 2024 | B608042 |
B2418060 | Certificate of Analysis | Jan 05, 2024 | B608042 |
B2418061 | Certificate of Analysis | Jan 05, 2024 | B608042 |
B2418062 | Certificate of Analysis | Jan 05, 2024 | B608042 |
1. Herrmann FE, Hesslinger C, Wollin L, Nickolaus P. (2022) BI 1015550 is a PDE4B Inhibitor and a Clinical Drug Candidate for the Oral Treatment of Idiopathic Pulmonary Fibrosis.. Front Pharmacol, 13 (3): (838449). [PMID:35517783] |